These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6331934

  • 1. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
    Strife CF, Jackson EC, McAdams AJ.
    Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
    [Abstract] [Full Text] [Related]

  • 2. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF, McEnery PT, McAdams AJ, West CD.
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [Abstract] [Full Text] [Related]

  • 3. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC, West CD, Strife CF.
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [Abstract] [Full Text] [Related]

  • 4. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
    Srp Arh Celok Lek; 1999 Dec; 127(5-6):163-71. PubMed ID: 10500423
    [Abstract] [Full Text] [Related]

  • 5. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
    Abreo K, Moorthy AV.
    Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
    [Abstract] [Full Text] [Related]

  • 6. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
    Strife CF, McAdams AJ, West CD.
    Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
    Iitaka K, Moriya S, Nakamura S, Tomonaga K, Sakai T.
    Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
    [Abstract] [Full Text] [Related]

  • 8. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
    McEnery PT, McAdams AJ, West CD.
    Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K, Nakamura S, Moriya S, Koshino H, Iwasaki N, Motoyama O, Sakai T.
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
    Taguchi T, Bohle A.
    Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
    [Abstract] [Full Text] [Related]

  • 11. Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study.
    Lamb V, Tisher CC, McCoy RC, Robinson RR.
    Lab Invest; 1977 Jun; 36(6):607-17. PubMed ID: 325295
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and glomerular immunofluorescence of renal biopsies from children with nephrotic syndrome due to minimal change disease and two variants of mesangial proliferative glomerulonephritis.
    Hui A, Poucell S, Thorner P, Rance CP, Baumal R.
    Int J Pediatr Nephrol; 1984 Mar; 5(1):5-10. PubMed ID: 6370883
    [Abstract] [Full Text] [Related]

  • 13. [Membranoproliferative glomerulonephritis. Variability of a morphologically definable disease].
    Anders D, Bläker F, Gekle D, Kehrberg H.
    Klin Padiatr; 1982 Mar; 194(3):173-81. PubMed ID: 7132223
    [Abstract] [Full Text] [Related]

  • 14. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
    Davis AE, Schneeberger EE, Grupe WE, McCluskey RT.
    Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
    [Abstract] [Full Text] [Related]

  • 15. Histological, ultrastructural and immunofluorescence studies in membranoproliferative glomerulonephritis.
    Nagi AH.
    J Pathol; 1972 Mar; 106(3):151-4. PubMed ID: 4114030
    [No Abstract] [Full Text] [Related]

  • 16. Mesangiocapillary glomerulonephritis: a long-term study of 40 cases.
    Swainson CP, Robson JS, Thomson D, MacDonald MK.
    J Pathol; 1983 Dec; 141(4):449-68. PubMed ID: 6363655
    [Abstract] [Full Text] [Related]

  • 17. Clinical and histopathological studies in human renal disease. V. Histological, immunohistological and electron microscopic finding in follow-up biopsies.
    Beregi E, Varga I.
    Acta Med Acad Sci Hung; 1973 Dec; 30(4):251-64. PubMed ID: 4600053
    [No Abstract] [Full Text] [Related]

  • 18. [Membranoproliferative glomerulonephritis. Morphological observations and considerations on pathogenesis].
    Anders D.
    Immun Infekt; 1982 Nov; 10(6):219-29. PubMed ID: 6764212
    [Abstract] [Full Text] [Related]

  • 19. Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children.
    McEnery PT, McAdams AJ.
    Am J Kidney Dis; 1988 Aug; 12(2):138-46. PubMed ID: 3400634
    [Abstract] [Full Text] [Related]

  • 20. Experimental infections with African Trypanosomes. VI. Glomerulonephritis involving the alternate pathway of complement activation.
    Nagle RB, Ward PA, Lindsley HB, Sadun EH, Johnson AJ, Berkaw RE, Hildebrandt PK.
    Am J Trop Med Hyg; 1974 Jan; 23(1):15-26. PubMed ID: 4204023
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.